Accordingly, therapeutic strategies based on the key targets of ferroptosis, such as GPX4, ferroptosis suppressor protein 1 (FSP1) and GCH1, are capable of reversing cancer drug resistance and interrupting tumour progression.142. This evidence concerns the gene GCH1 and neoplasm.